Skip to search formSkip to main contentSkip to account menu

Macroprolactinoma

Known as: Macroprolactinomas 
A pituitary prolactin cell adenoma of more than 10 mm diameter. [HPO:probinson]
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Prolactinoma

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Coexistence of a pituitary macroadenoma and multicentric paraganglioma: a strange coincidence.
2011
2011
Efficacy of the combined cabergoline and octreotide treatment in a case of a dopamine-agonist resistant macroprolactinoma
Prolactinomas in males can be voluminous macroadenomas invading the surrounding structures. Medical therapy with dopamine… 
Review
2011
Review
2011
Secondary resistance to cabergoline therapy in a macroprolactinoma: a case report and literature review
Primary resistance to dopamine agonists occurs in 10–15% of prolactinomas but secondary resistance following initial biochemical… 
2007
2007
A case of macroprolactinoma encasing an internal carotid artery aneurysm, presenting as pituitary apoplexy
We present the first case of successful non-surgical treatment of an internal carotid aneurysm, embedded within a… 
2001
2001
A comparative evaluation of effectiveness of medical and surgical therapy in patients with macroprolactinoma.
BACKGROUND The surgical success rate in macroprolactinomas is quite low, while medical treatment is more effective in reducing… 
1993
1993
Long term therapy of patients with macroprolactinoma using repeatable injectable bromocriptine.
The efficacy and tolerability of a long term treatment (21-53 months; mean, 36) with a new injectable form of bromocriptine… 
1993
1993
Reversible dementia due to macroprolactinoma. Case report.
Subfrontal tumors are an infrequent cause of dementia. Most of those that do cause dementia are meningiomas, and the symptoms may… 
Review
1991
Review
1991
Surgical outcome and pathological effects of bromocriptine preoperative treatment in prolactinomas.
Highly Cited
1984
Highly Cited
1984
Bromocriptine treatment reduces the cell size in human macroprolactinomas: a morphometric study.
A morphological study was carried out on eight macroprolactinomas surgically removed from untreated patients and on nine… 
1982
1982
Bromocriptine treatment of macroprolactinomas: studies on the time course of tumor shrinkage and morphology
The effects of Bromocriptine (Brc) (7.5 2 - 15 mg/day for 45 days) on serum PRL levels and tumor size and morphology were… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)